2021 annual financial data
Denali Therapeutics 2021 Operating cash flow margin
Denali Therapeutics 2021 operating cash flow margin with verified reported valu…
Direct answer
Operating cash flow margin was -434.41%.
Operating income was -295,751,000 USD and net income was -290,581,000 USD.
Operating cash flow was -211,389,000 USD.
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 48,661,000 USD
- Operating income
- -295,751,000 USD
- Net income
- -290,581,000 USD
- Operating cash flow
- -211,389,000 USD